Particularly, Gi/o activates pro-survival pathways PI3K/Akt or Ras/MAPK/ERK that lead to the increased cell proliferation and growth of the cancer cells, making chemotherapeutic drugs causing apoptosis inefficient [34]. Here, AKT1 is linked to cancer.